Servicio de Información Comunitario sobre Investigación y Desarrollo - CORDIS

CORDIS reúne toda la información sobre los proyectos financiados por Horizonte 2020 , y ahora también resúmenes de los informes relacionados. Se puede descargar toda la documentación de estos proyectos en el Portal de datos abiertos de la UE .

My refinements


Download results of this page


Restringir por:

Tipo de contenido

Proyecto (115)
Informe resumido (6)

País

Alemania (71)
Argentina (1)
Australia (1)
Austria (14)
Brasil (3)
Bélgica (42)
Camboya (1)
Canadá (3)
Chequia (7)
China (1)
Chipre (1)
Colombia (3)
Corea del Sur (1)
Croacia (3)
Cuba (2)
Dinamarca (24)
Ecuador (1)
Eslovaquia (4)
Eslovenia (4)
España (54)
Estados Unidos (13)
Estonia (5)
Finlandia (11)
Francia (57)
Grecia (7)
Hungría (4)
Irlanda (13)
Israel (13)
Italia (50)
Jamaica (1)
Kirguistán (1)
Letonia (3)
Luxemburgo (3)
México (1)
Noruega (13)
Nueva Caledonia (1)
Países Bajos (60)
Perú (1)
Polinesia Francesa (1)
Polonia (11)
Portugal (12)
Reino Unido (62)
Rumanía (4)
Senegal (2)
Sudáfrica (2)
Suecia (23)
Suiza (13)
Taiwán (1)
Turquía (2)
Uganda (2)
Vietnam (1)

Advanced search

Búsqueda de proyectos y resultados

Results 1 - 10 of 121
Results/page:
12 3 4 5 6 7 8 9 10 > >| 
Developing the iTOP kit: Empowering scientists with efficient intracellular delivery of biologicals in hard-to-manipulate cell types
ID: 777783
Fecha de inicio: 2017-09-01, Fecha de finalización: 2019-08-31
NTrans Technologies BV has developed iTOP; a novel and extremely effective method to deliver highly relevant bioactive molecules (including DNA, RNA, active proteins, and their combinations) into mammalian cells. This includes the efficient delivery of such molecules inside...
Programme: H2020-EU.3.1.3.
Record Number: 211973
Last updated on: 2017-08-25
Efficacy and safety of thrombectomy in stroke with extended lesion and extended time window: a randomized, controlled trial
ID: 754640
Fecha de inicio: 2018-01-01, Fecha de finalización: 2022-12-31
TENSION (efficacy and safety of ThrombEctomy iN Stroke with extended leSION and extended time window: a randomized, controlled trial) strives at providing innovative treatment to patients with severe stroke to reduce the individual and societal burden of death and dependency...
Programme: H2020-EU.3.1.3.
Record Number: 212667
Last updated on: 2018-01-18
PREvention of STroke in Intracerebral haemorrhaGE survivors with Atrial Fibrillation
ID: 754517
Fecha de inicio: 2017-12-01, Fecha de finalización: 2022-11-30
Intracerebral hemorrhage (ICH) is a severe stroke subtype causing higher mortality and more disability than other strokes. 20% of ICH survivors have atrial fibrillation (AF), a major cause of ischemic stroke (IS). While IS in AF patients is generally prevented by oral...
Programme: H2020-EU.3.1.3.
Record Number: 212666
Last updated on: 2018-01-18
How to best meet the needs of people with dementia with severe behavioural disturbances. Toward a respectful and cost-effective model
ID: 779237
Fecha de inicio: 2018-01-01, Fecha de finalización: 2022-12-31
The RECAGE project will tackle one of the most challenging problem arising during the clinical course of dementia: the so-called Behavioural and Psychological Symptoms of Dementia (BPSD). The current state-of-the-art of the treatment of these symptoms is still unsatisfactory...
Programme: H2020-EU.3.1.3.
Record Number: 216103
Last updated on: 2018-06-28
Normothermic Perfusion Device for Renal and Hepatic Preservation and Viability Assessment
ID: 804252
Fecha de inicio: 2018-06-01, Fecha de finalización: 2020-11-30
EBERS is a leading company in the field of bioreactors and cell culture systems, with a wide international presence in Europe, USA, Australia, and Asia. In the NORMOPERF project we go a step further by targeting the organ transplantation field by bringing to the healthcare...
Programme: H2020-EU.3.1.3.
Record Number: 216349
Last updated on: 2018-06-28
Scale-up of Prevention and Management of Alcohol Use Disorders and Comorbid Depression in Latin America
ID: 778048
Fecha de inicio: 2017-12-01, Fecha de finalización: 2021-11-30
Following the strategic approach of the Global Alliance for Chronic Diseases (GACD) to support optimal approaches to implement existing knowledge, SCALA implements and evaluates an evidence-based approach to scale up prevention and management of Alcohol Use Disorders (AUD) and...
Programme: H2020-EU.3.1.3.
Record Number: 213001
Last updated on: 2018-01-24
EMBRYON - Develop and commercialize a highly innovative diagnostic-imaging product, improving success rates in the Assisted Reproduction IVF sector
ID: 664101
Fecha de inicio: 2015-03-01, Fecha de finalización: 2015-08-31
Infertility is a heavy social issue,experienced by nearly one in six couples during reproductive lifetime.In Vitro Fertilization (IVF) is growing 8-10% p.a.,to 1.5 million therapy cycles and 7.5 billion dollars in 2013.Despite stressful and costly procedures,IVF success rate...
Programme: H2020-EU.3.1.3.
Record Number: 196305
Last updated on: 2016-11-29
St. Bernard - Emergency EEG and auditory evoked potentials for earlier diagnostics and treatment planning of unconscious patients
ID: 662657
Fecha de inicio: 2015-02-01, Fecha de finalización: 2015-07-31
An ambulance crew is dispatched to help an unconscious man lying in the street. Is he having a stroke? Is he haemorrhaging in the brain? Has he hit his head? Is he an epileptic? Should the crew start thrombolytic treatment, stabilize the patient or give benzodiazepine? What...
Programme: H2020-EU.3.1.3.
Record Number: 196190
Last updated on: 2017-03-20
Clinical validation of the CD32b biomarker on the European market
ID: 673735
Fecha de inicio: 2015-05-01, Fecha de finalización: 2015-09-30
The overall objective of the proposed project is the clinical validation of a novel biomarker for B-cell malignancies. The presently most widely used anti-CD20 antibody treatment rituximab has considerably improved treatment options for patients with B-cell malignancies...
Programme: H2020-EU.3.1.3.
Record Number: 196534
Last updated on: 2015-05-01
Clinical proof of concept through a randomised phase II study: a combination of immunotherapy and stereotactic ablative radiotherapy as a curative treatment for limited metastatic lung cancer
ID: 733008
Fecha de inicio: 2017-01-01, Fecha de finalización: 2022-12-31
IMMUNOSABR is geared towards opening up a new paradigm in treating metastatic cancer by obtaining clinical proof of concept for a novel bi-modal curative treatment strategy. High precision stereotactic ablative radiotherapy (SABR) is combined with immunotherapy to form a...
Programme: H2020-EU.3.1.3.
Record Number: 207443
Last updated on: 2017-07-17
12 3 4 5 6 7 8 9 10 > >| 
List retrieved on: 2018-07-19
Síganos en: RSS Facebook Twitter YouTube Gestionado por la Oficina de Publicaciones de la UE Arriba